Special Offer: Get 50% off your first 2 months when you do one of the following
Personalized offer codes will be given in each session
About This Webinar

There are several dosing regimen in place to counter antimicrobial resistance (AMR), according to the World Health Organization (WHO). In this webinar of our webinar series on antibiotics, we want to highlight two of them as Oral Solid Dosage (OSD) formulations in hard capsules.

One is the use of fixed-dose combination (FDC) therapies consisting of more than one antibiotic in a single dose or hard capsule respectively. Of course, FDC’s also pose some inherent issues and so far only a few are approved by the US FDA, or included on the WHO Essential Medicines List (EML). Nevertheless, such FDC’s gain importance in many countries, among them India and China. Therefore, we expect more clinical trials in this direction. Suitable laboratory equipment is needed.
Another formulation is the change from systemic (delivery) to delivery into the lungs. Attracted by the clinical benefits observed in cystic fibrosis (CF) and the availability of dry powder antibiotic formulations, there has been a growing interest in the use of inhaled antibiotics.

We want to look into the dosing technologies to manufacture such hard capsule based formulations (on our capsule filling equipment), from clinical stage to large-scale manufacturing. Besides the dosing applications, we also would like to elaborate on operator protection measures and cleaning validation.

TARGET GROUP
Production line managers, Machine owners, Technicians, Project lead buyers, Project engineering, Technical consultants, clinitions, researcher in pre-clinical and clinical development (R&D), formulation developers (galenics)

PLEASE NOTE
This webinar is part of our Antibiotics webinar series. Four of our sites will give you a complete overview: from liquids and powders to tablets and capsules, you will learn everything you need to know about the background and technologies related to antibiotic production in our new webinar series: https://www.syntegon.com/new-webinar-series-about-antibiotics-production

Agenda
  • Infectious diseases
  • Which active substances exist and are currently under development?
  • Comparison of systemic (IV) versus inhaled antibiotics
  • Why OSD (Oral Solid Dosage)?
  • Diverse dosing technologies, clinical development and manufacturing scale
  • Combination dosing and quality control
  • Dosing of dry-powders for inhalation (DPI) and quality control
  • Operator protection measures
  • Cleanability
  • 15 min Q&A session
Categories:
BUSINESS & FINANCE EDUCATION & LEARNING HEALTH & WELLNESS SCIENCE & TECH
When: Wed, Dec 8, 2021 · 10:00 AM · Berlin
Duration: 1 hour
Language: English
Who can attend? Anyone with the event link can attend
Dial-in available? (listen only): No
Featured Presenters
Webinar hosting presenter
Director Product Management
After training as an electronics technician, Matthias Mössinger first studied applied physics at Heilbronn University and then technical business administration at the University of Stuttgart. After working in various industries, he joined the mechanical and plant engineering sector for the pharmaceutical industry in 2001. After 14 years in a leading position in international new machine sales, and a 4-year responsibility for the business development of various drug delivery devices, he joined Syntegon in 2019 as Senior Market Expert in the Pharma Solid division. In this role, he is responsible for the planning and development of the "Tablet Presses and Capsule Filling Machines" business segment.